Holen Sie sich die Stockscreener-App
1.80
3.23%
-0.06
Handel nachbörslich:
1.78
-0.02
-1.11%
Finanzdaten der Neumora Therapeutics Inc-Aktie (NMRA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
23.82%
54.04
|
70.94 | 76.65 | 63.82 | 60.07 |
| Operating Income/Loss |
23.82%
-54.04
|
-70.94 | -76.65 | -63.82 | -60.07 |
| Nonoperating Income/Loss |
56.25%
1.334
|
3.049 | 4.152 | 5.247 | 6.353 |
| Income/Loss From Continuing Operations Before Tax |
22.36%
-52.71
|
-67.89 | -72.49 | -58.58 | -53.72 |
| Income Tax Expense/Benefit |
76.19%
0.025
|
0.105 | 0.053 | 0.125 | - |
| Income/Loss From Continuing Operations After Tax |
22.45%
-52.73
|
-67.99 | -72.55 | -58.70 | -53.72 |
|
Net Income/Loss
|
22.45%
-52.73
|
-67.99 | -72.55 | -58.70 | -53.72 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.15%
161.69
|
161.45 | 159.58 | 158.98 | 157.94 |
| Diluted Average Shares |
0.15%
161.69
|
161.45 | 159.58 | 158.98 | 157.94 |
| Basic Earnings Per Share |
21.43%
-0.33
|
-0.42 | -0.45 | -0.37 | -0.34 |
| Diluted Earnings Per Share |
21.43%
-0.33
|
-0.42 | -0.45 | -0.37 | -0.34 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):